ResearchProjects

This study will utilize Multiphase Optimization Strategy (MOST) to optimize smoking cessation treatment for HIV clinical care by targeting patient barriers to quitting and clinical care barriers to reaching and effectively treating a broad heterogeneous population of smokers living with HIV. Given that over 75% of the 1.2 million persons living with HIV in the U.S. receive HIV clinical care annually, the results of this study will have a significant public health impact by optimizing a cost-effective, sustainable and immediately scalable smoking cessation package tailored specifically for the HIV clinical care context. Findings will also add to scientific knowledge by providing a clear basis for further improvement of cessation interventions for smokers living with HIV.